An evidence based approach to treat “Dyslipidemia”

dyslipidemia

Identification and treatment of dyslipidemia is necessary to reduce the rate of atherosclerosis and the subsequent cardiovascular events, including coronary artery disease (CAD), which may be pharmacologic or non pharmacologic. Patients with abnormal lipid profiles (dyslipidemia) shall be identified and treated on the basis of patients’ risk profiles. Important points regarding the diagnosis of dyslipidemia: … Read moreAn evidence based approach to treat “Dyslipidemia”